Back
Protalix BioTherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
PLX
Protalix BioTherapeutics
Last Price:
$1.61
Seasonality Move:
3.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight buying pressure.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.61 | Sell |
| 20-day SMA: | 1.82 | Sell |
| 50-day SMA: | 2.31 | Sell |
| 200-day SMA: | 1.82 | Sell |
| 8-day EMA: | 1.62 | Sell |
| 20-day EMA: | 1.84 | Sell |
| 50-day EMA: | 2.12 | Sell |
| 200-day EMA: | 1.96 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 32.94 | Sell |
| Chaikin Money Flow: | 76115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.45 - 2.65) | Sell |
| Bollinger Bands (100): | (1.97 - 2.73) | Sell |
Protalix BioTherapeutics Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.60 while PLX 8-day simple moving average is 1.61, which is a Sell signal.
-
The stock price of PLX is 1.60 while Protalix BioTherapeutics 20-day SMA is 1.82, which makes it a Sell.
-
Protalix BioTherapeutics 50-day simple moving average is 2.31 while PLX share price is 1.60, making it a Sell technically.
-
PLX stock price is 1.60 and Protalix BioTherapeutics 200-day simple moving average is 1.82, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $1.60. The Score for PLX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
127.4M
Price in USD:
1.60
Share Volume:
532.8K
Protalix BioTherapeutics 52-Week Range
52-Week High:
3.10
52-Week Low:
0.82
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 1.60 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.60 while PLX 8-day exponential moving average is 1.62, which is a Sell signal.
-
The stock price of PLX is 1.60 while Protalix BioTherapeutics 20-day EMA is 1.84, which makes it a Sell.
-
Protalix BioTherapeutics 50-day exponential moving average is 2.12 while PLX share price is 1.60, making it a Sell technically.
-
PLX stock price is 1.60 and Protalix BioTherapeutics 200-day simple moving average is 1.96, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Protalix BioTherapeutics is a Sell
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 32.94, which suggest Protalix BioTherapeutics is oversold
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (1.45 - 2.65), which suggest Protalix BioTherapeutics is a Sell
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (1.97 - 2.73), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.